Simon Rule, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer, Brad Kahl, José-Ángel Hernández-Rivas, Keqin Qi, Sanjay Deshpande, Lori Parisi and Michael Wang (2019) “Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis”, Haematologica. Pavia, Italy, 104(5), pp. e211-e214. doi: 10.3324/haematol.2018.205229.